首页 | 本学科首页   官方微博 | 高级检索  
检索        

可博利口服液澄清工艺研究
引用本文:黄筱琴,万国兰,李春.可博利口服液澄清工艺研究[J].中国医药导报,2008,5(11):46-47.
作者姓名:黄筱琴  万国兰  李春
作者单位:南昌市第九医院,江西南昌,330002
摘    要:目的:研究可博利口服液的澄清工艺。方法:以两种不同工艺配制制剂,比较总固体物含量,并采用正交试验法,以冬虫夏草多糖含量及总固体物含量为指标,优选澄清工艺,再进行稳定性考察的比较。结果:壳聚糖澄清工艺的总固体物含量比原工艺高14.7%,优选的澄清工艺为药液温度50℃、药液浓度(g∶ml)=1∶4、1%壳聚糖的用量为3%(W/W)。结论:本实验简化了壳聚糖澄清工艺,使有效成分的总保留量得到提高,且制剂稳定。

关 键 词:冬虫夏草多糖  正交试验法  壳聚糖
文章编号:1673-7210(2008)04(b)-046-02
修稿时间:2007年12月13

Study on clarification process of Keboli Oral Solution
HUANG Xiao-qin,WAN Guo-lan,LI Chun.Study on clarification process of Keboli Oral Solution[J].China Medical Herald,2008,5(11):46-47.
Authors:HUANG Xiao-qin  WAN Guo-lan  LI Chun
Institution:(The Ninth Hospital of Nanchang,Nanchang 330002,China)
Abstract:Objective:To study the clarification process of Keboli Oral Solution.Methods:Two processes were applied,comparing the extract percents.The orthogonal design test was used to obtain the optimum preparation process with cordycepin polysaccharide as marker.Stability of the two preparations were compared.Results:Extract percent of chitosan flocculation was 14.7% higher than the original process.The optimized conditions were that 3%(W/W)chitoson flocculating agent was added at 50℃ with durg solution concentration of 1∶4(g∶ml).Conclusion:The optimum process is simple,can reserve more effective components and has a good stability.
Keywords:Cordycepin polysaccharide  Orthogonal design test  Chitosan
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号